Pfizer said this week it’s begun testing a third dose of its COVID vaccine and a new modified version to address variants for years to come. The Pfizer-BioNTech COVID vaccine is not yet licensed by the FDA but has obtained Emergency Use Authorization (EUA) to prevent COVID-19 for use in ages 16 years and older. The emergency use of this vaccine is only authorized as long as “circumstances exist justifying the authorization of emergency use.” The FDA has said it is willing to authorize booster shots based on small clinical trials, accepting data on how well vaccines prime the immune system rather than holding out for long-term safety and efficacy results on protecting against COVID-19.
https://childrenshealthdefense.org/defender/pfizer-ceo-annual-vaccine-covid
[dntplgn recurring_amt1=”4.50″ recurring_amt2=”3.00″ recurring_amt3=”1.50″ item_name=”Donation for EarthNewspaper.com” paypal_email=”mark@eimagine.net” currency_code=”USD” currency_symbol=”$” return_url=” https://earthnewspaper.com/index.php/thank-you-for-donating-to-earthnewspaper-com”]